Has Beverly Whittenberg, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,885 in general payments to Beverly Whittenberg, MD across 353 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Beverly Whittenberg, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Beverly Whittenberg, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Beverly Whittenberg, MD

Interventional Pain Medicine · Fairfax, VANPI 1366483034

Payments from drug & device makers

$9,885in general payments, 2019–2025

Across 353 payments — averaging $28.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nalu Medical, Inc.$1K
AbbVie$1K
Medtronic$1K
Collegium Pharmaceutical, Inc.$815
Abbott$656
IBSA Pharma Inc.$378
plus $4K from 43 others

What the payments were for

Travel & lodging$1,01810%
Food & beverage$8,86790%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nalu Medical, Inc.	7	$1,275
AbbVie(2 entities)	48	$1,260
Medtronic(2 entities)	32	$1,182
Collegium Pharmaceutical, Inc.	60	$815
Abbott	31	$656
IBSA Pharma Inc.	21	$378
Vertos Medical, Inc.	3	$372
Nevro Corp.	9	$339
Scilex Pharmaceuticals Inc.	16	$309
Pfizer	16	$290
Globus Medical	7	$214
GRT US Holding, Inc.	5	$202
Foundation Fusion Solutions, LLC	1	$192
Biotronik NRO, Inc.	3	$171
Lilly USA, LLC	7	$163
Boston Scientific	6	$149
Almatica Pharma LLC	7	$144
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$135
Assertio Therapeutics, Inc.	6	$129
Bioventus LLC	2	$122
Teva Pharmaceuticals USA, Inc.	6	$116
Spinal Simplicity, LLC	1	$109
Amgen(2 entities)	6	$108
Pacira Pharmaceuticals Incorporated	1	$100
Axogen	1	$91
Providence Medical Technology, Inc.	1	$80
Arbor Pharmaceuticals, Inc.	5	$80
Averitas Pharma Inc.	3	$77
Lundbeck LLC	3	$70
Biodelivery Sciences International, Inc.	4	$58
Johnson & Johnson	2	$53
MDD US Operations, LLC	2	$46
Hikma Pharmaceuticals USA	3	$44
Vertex	2	$44
Redhill Biopharma Inc.	2	$35
Stryker	1	$31
Radius Health, Inc.	2	$26
Si-bone, Inc.	1	$25
Takeda Pharmaceuticals U.S.A., Inc.	2	$22
Protega Pharmaceutials Inc	1	$21
Valinor Pharma, LLC	1	$21
Baudax Bio Inc.	1	$21
Pacira Therapeutics, Inc.	1	$20
Ferring Pharmaceuticals Inc.	1	$20
Azurity Pharmaceuticals, Inc.	1	$19
Daiichi Sankyo Inc.	1	$17
Curonix LLC	1	$14
Shionogi Inc	1	$13
Electronic Waveform Lab, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,885 in reported general payments places this provider in the 70th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia →

Medicare billing

Part B allowed, 2024

$272,470

Medicare patients

250

Services billed

2,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	14	$269
Gabapentin	16	$249
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$212

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Fairfax

Marina ProtopapasFairfax$9K
Rodney DadeFairfax$4K
David KimFairfax$3K
Robert WagnerFairfax$3K
Su Min KoFairfax$483
Talal GhazalArlington$248K
Ketan PatelHaymarket$133K
Che TorryNewport News$48K
Benjamin SeemanRichmond$28K
Niteesh BhararaReston$25K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →